Koesten, Hirschmann & Crabtree, Inc. Pfizer Inc Transaction History
Koesten, Hirschmann & Crabtree, Inc.
- $172 Billion
- Q3 2024
A detailed history of Koesten, Hirschmann & Crabtree, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Koesten, Hirschmann & Crabtree, Inc. holds 1,378 shares of PFE stock, worth $36,324. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,378
Previous 1,366
0.88%
Holding current value
$36,324
Previous $37.9 Million
5.22%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding PFE
# of Institutions
3,260Shares Held
3.61BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13.6 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.2 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.66 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.32 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.43 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $148B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...